Junior professor Dr. phil. Alexander Titz, currently head of a research group at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) and junior professor at Saarland University
An important line of defence in the fight against the new corona virus SARS-CoV-2 is the formation of neutralising antibodies. These can eliminate the intruders and have great potential to be used for
After 13 years, international Infectious Diseases and Respiratory Medicine societies have jointly issued new recommendations for the treatment of patients with nontuberculous mycobacteria (NTM). Curre
More than half of the world's population is infected with the cytomegalovirus. The majority of people don't even notice the infection, since their immune systems keep the virus in check. Groups of T
So far, allogeneic stem cell transplantation for the treatment of severe blood cancers has been the only medical intervention to have cured at least three people infected with the HI virus (HIV). It
Dr Christian Keller, from Philipps-University Marburg and the German Center for Infection Research, and Dr Anke Osterloh, Research Center Borstel, were awarded this year’s "Memento Award for neglected
The search for effective drugs against the new coronavirus is currently a top priority at the German Center for Infection Research (DZIF). Developing inhibitors of viral replication is a promising
Currently, little is known about children and their susceptibility to the new coronavirus. It has been observed that young children have rarely presented with COVID-19 up to now. No specific
An international consortium found a remarkable global spread of strains of a multi-resistant bacterium that can cause severe infections – Stenotrophomonas maltophilia. The study, published under the
